More about

Retinal Disease

News
July 20, 2023
1 min read
Save

Caeregen Therapeutics receives $1.4 million research grant for retinal disease candidate

Caeregen Therapeutics receives $1.4 million research grant for retinal disease candidate

Caeregen Therapeutics has been awarded a $1.4 million phase 2 Small Business Innovation Research grant for the development of CTR-107 for the treatment of retinal-related vision loss due to inherited and age-related diseases.

News
June 26, 2023
1 min watch
Save

VIDEO: Extended-durability agents changing the landscape of retinal diseases

VIDEO: Extended-durability agents changing the landscape of retinal diseases

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Rishi P. Singh, MD, summarizes the content of his presentation on emerging therapies for retinal diseases.

News
June 13, 2023
1 min read
Save

Beacon Therapeutics launches with focus on retinal disease gene therapies

Beacon Therapeutics launches with focus on retinal disease gene therapies

Beacon Therapeutics has launched with the goal of developing a new generation of gene therapies for a range of retinal diseases, according to a press release.

News
May 04, 2023
2 min read
Save

Despite retinopathy concerns, hydroxychloroquine still proven to boost survival in lupus

Despite retinopathy concerns, hydroxychloroquine still proven to boost survival in lupus

DESTIN, Fla. — Hydroxychloroquine remains one of the most important drugs in lupus management and should be used as background therapy in nearly all cases, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.

News
April 06, 2023
3 min read
Save

What area of ophthalmology can benefit the most from AI?

What area of ophthalmology can benefit the most from AI?

I am a retina specialist, so I am obviously partial to retinal diseases. However, I think we have already made a lot of headway in developing machine learning models for identifying diseases in the retina, and we are on our way to do more.

News
December 29, 2022
1 min read
Save

Opus Genetics acquires two gene therapy candidates from Iveric Bio

Opus Genetics acquires two gene therapy candidates from Iveric Bio

Opus Genetics has acquired the rights to develop two preclinical-stage AAV-based gene therapy product candidates for inherited retinal diseases from Iveric Bio, according to a company press release.

CME
Video

The Time Has Come: Surgical Administration of Durable Medical Therapy in Vascular Retinal Diseases

The Time Has Come: Surgical Administration of Durable Medical Therapy in Vascular Retinal Diseases
1.25 CME
75 MINS
$0 FEE
CME
Video

Extending the Span of Time in nAMD and DME Management

Extending the Span of Time in nAMD and DME Management
0.75 CME
45 MINS
$0 FEE
News
November 17, 2022
2 min watch
Save

VIDEO: Gene therapy shows growing promise in treatment of retinal diseases

VIDEO: Gene therapy shows growing promise in treatment of retinal diseases

NEW YORK — In this Healio Video Perspective from OSN New York Retina, Lejla Vajzovic, MD, FASRS, discusses the growing role of intravitreal and subretinal gene therapy in treating retinal diseases.

News
November 14, 2022
3 min watch
Save

VIDEO: Neuro-ophthalmic, retinal diseases can present challenge for eye care providers

VIDEO: Neuro-ophthalmic, retinal diseases can present challenge for eye care providers

In this Healio video, Bisant A. Labib, OD, FAAO, Dipl(CEC), associate professor at Pennsylvania College of Optometry at Salus University, discusses a symposium at Academy 2022 on the management of neuro-retinal diseases.

View more